Benign neoplasm: Brain, supratentorial

CD2_BENIGN_BRAIN_SUPRATENT

salivary gland neoplasm: ['Tumors of the SALIVARY GLANDS.']

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D33.0
Hospital discharge: ICD-9 $!$
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D33.0
Cause of death: ICD-9 $!$
Cause of death: ICD-8 $!$

328

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

328

diagram downward connector

Check minimum number of events None

328

diagram downward connector

Include endpoints None

328

diagram downward connector
CD2_BENIGN_BRAIN_SUPRATENT

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D33
Name in latin Neoplasma benignum cerebri supratentoriale

Summary Statistics

Key figures

All Female Male
Number of individuals 316 169 147
Unadjusted prevalence (%) 0.10 0.10 0.11
Mean age at first event (years) 48.57 46.86 50.54

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.34 [0.31, 5.83] 6.9e-1 23
15 years 0.00 0.70 [0.14, 3.51] 6.6e-1 11
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_BENIGN_BRAIN_SUPRATENT – Benign neoplasm: Brain, supratentorial
GWS hits: 0

Survival analyses between endpoints

Plot

before Benign neoplasm: Brain, supratentorial
after Benign neoplasm: Brain, supratentorial

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benign neoplasm: Brain, supratentorial